Colitis
MONDO:0005292Inflammation of the colon.
Also known as: colitis, colitis (disease), colon inflammation, inflammation of colon
702 clinical trials for this condition and its sub-types, 41 tagged with Colitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Colitis
-
Ulcerative colitis 579 trials
2 sub-types
- Distal colitis 0 trials
- Pancolitis 0 trials
-
Infectious colitis 0 trials · 69 incl. sub-types
1 sub-type
- Clostridium difficile colitis 69 trials
-
Indeterminate colitis 26 trials
-
Proctocolitis 2 trials · 7 incl. sub-types
2 sub-types
- Food protein-induced allergic proctocolitis 5 trials
- Proctosigmoiditis 0 trials
-
Ileocolitis 5 trials
-
Microscopic colitis 3 trials · 5 incl. sub-types
3 sub-types
- Eosinophilic colitis 2 trials
- Collagenous colitis 0 trials
- Lymphocytic colitis 0 trials
-
Chemical colitis 3 trials
-
Diversion colitis 2 trials
-
Ischemic colitis 0 trials
-
New hope for ulcerative colitis? drug trial shows promise
Disease control Stopped earlyThis study tested a drug called vixarelimab in 79 people with moderate to severe ulcerative colitis (UC) who had not responded well to other treatments. The goal was to see if the drug could help control the disease and reduce symptoms like diarrhea and bleeding. The study was st…
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Promising UC drug trial halted early
Disease control Stopped earlyThis study tested a drug called bertilimumab in 32 adults with moderate to severe ulcerative colitis. The goal was to see if it could reduce disease activity compared to a placebo. The trial was terminated early, so results are limited and no clear benefit was established.
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Antibiotic teicoplanin tested for stubborn gut infection
Disease control Stopped earlyThis study tested the antibiotic teicoplanin (taken by mouth twice daily for 7 to 14 days) in 50 adults hospitalized with C. difficile infection causing diarrhea and colitis. The goal was to see if it could stop diarrhea and prevent it from coming back. The trial was terminated e…
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis Stopped earlyThis study tested a new imaging tool called multispectral optoacoustic tomography (MSOT) to see if it could safely detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. The device uses light and sound to create images of inflamed areas. The tr…
Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC